NEW YORK LIFE INVESTMENT MANAGEMENT LLC
Q3 2022 13F-HR Holdings
Net value change ($000)
-357,289
(-4.1%)
New positions
43
Sold out positions
91
Turnover %
4.9%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Zendesk, Inc. | 41,808 | NEW |
| 1Life Healthcare Inc | 35,734 | NEW |
| New York Life Investments ETF Trust | 23,082 | NEW |
| AVALARA, INC. | 22,211 | NEW |
| Global Blood Therapeutics, Inc. | 22,166 | NEW |
| TSLA | 21,341 | 23.9% |
| MMCA | 19,414 | 1981.0% |
| TBLL | 17,218 | 493.8% |
| VGIT | 17,070 | 63.5% |
| VONV | 16,028 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| New York Life Investments ETF Trust | -47,921 | -44.1% |
| IQSU | -34,210 | -10.4% |
| MSFT | -29,042 | -9.6% |
| PLANTRONICS INC /CA/ | -21,946 | -100.0% |
| New York Life Investments ETF Trust | -20,193 | -7.3% |
| IEFA | -17,771 | -29.6% |
| Mandiant, Inc. | -16,422 | -100.0% |
| CTXS | -15,444 | -88.4% |
| GVI | -14,151 | -87.8% |
| VONAGE HOLDINGS CORP | -13,855 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|